Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quetiapine XR Monotherapy or Adjunctive Therapy to Antidepressants in the Treatment of Major Depressive Disorder With Comorbid Generalized Anxiety Disorder

NCT00868374 is registered in ClinicalTrials.gov with Keming Gao as lead sponsor.

NCT NCT00868374
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00868374 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quetiapine XR Monotherapy or Adjunctive Therapy to Antidepressants in the Treatment of Major Depressive Disorder With Comorbid Generalized Anxiety Disorder
Lead sponsor
Keming Gao
Phase
Phase 3
Overall status
Terminated
Start date
June 30, 2008
Completion date
October 31, 2011
Enrollment
23 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

generalized anxiety disorder, major depressive disorder